BTW...I think the term "invited" originated from Charles's comments about being "invited" to apply for NIH and NSF funding. At least I vaguely recall seeing text to that effect. As such, it's easy to draw from that a sequence of funding invitation > lab relocation at TAMU > OWS connection. I think, therein, is the "beyond coincidence" aspect of where we are. Even so, a lot has to go right...the funding, the partnerships, the overcoming political games, etc. What is encouraging is that Charles's last PR volunteers that he will speak of "grants" and "collaborations" in the very near future, which just makes you feel like the rockets are about to launch in regards to the COVID play.
My fear is that IF these connections are not actualized, that the market will view that as a failure despite the fact that this stock will still be massively underpriced for the tech they do have.
Thus is the argument that pumping the stock might cause more harm than good and that letting it grow organically seems to be healthiest for the whole play.
Market Data 
Markets 
AI
